TW200612959A - Method for preparing hydroxamic acids - Google Patents

Method for preparing hydroxamic acids

Info

Publication number
TW200612959A
TW200612959A TW094118745A TW94118745A TW200612959A TW 200612959 A TW200612959 A TW 200612959A TW 094118745 A TW094118745 A TW 094118745A TW 94118745 A TW94118745 A TW 94118745A TW 200612959 A TW200612959 A TW 200612959A
Authority
TW
Taiwan
Prior art keywords
hydroxamic acids
preparing hydroxamic
preparing
processes
compound
Prior art date
Application number
TW094118745A
Other languages
English (en)
Inventor
Ting-Zhong Wang
Lalitha Krishnam
Joseph Zeldis
Jeremy I Levin
Jean Schmid
Mellard N Jennings
Huan-Qiu Li
Zhixin Wen
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of TW200612959A publication Critical patent/TW200612959A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
TW094118745A 2004-06-08 2005-06-07 Method for preparing hydroxamic acids TW200612959A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57778404P 2004-06-08 2004-06-08

Publications (1)

Publication Number Publication Date
TW200612959A true TW200612959A (en) 2006-05-01

Family

ID=35106941

Family Applications (2)

Application Number Title Priority Date Filing Date
TW094118744A TW200610523A (en) 2004-06-08 2005-06-07 Crystalline polymorphs of (3s)-n-hydroxy-4-({4-[(4-hydroxy-2-butynyl)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide
TW094118745A TW200612959A (en) 2004-06-08 2005-06-07 Method for preparing hydroxamic acids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TW094118744A TW200610523A (en) 2004-06-08 2005-06-07 Crystalline polymorphs of (3s)-n-hydroxy-4-({4-[(4-hydroxy-2-butynyl)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide

Country Status (6)

Country Link
US (2) US7179911B2 (zh)
AR (2) AR049073A1 (zh)
GT (1) GT200500139A (zh)
PA (2) PA8636101A1 (zh)
TW (2) TW200610523A (zh)
WO (2) WO2005123706A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1682537E (pt) 2003-11-05 2012-06-20 Sarcode Bioscience Inc Moduladores de adesão celular
GT200500139A (es) * 2004-06-08 2005-07-25 Metodo para la preparacion de acidos hidroxamicos
DK1881823T3 (en) 2005-05-17 2015-03-02 Sarcode Bioscience Inc COMPOSITION AND PROCEDURES FOR TREATMENT OF EYE DISORDERS
FR2898497B1 (fr) * 2006-03-20 2008-05-16 Galderma Res & Dev Utilisation de l'apratastat ou du (s)-n-hydroxy-4-(4-but-2- ynyloxy-benzenesulfonyl)-2,2-dimethyl-thiomorpholine-3-carbo xamide dans le traitement de pathologies inflammatoires cutanees
US7631568B2 (en) * 2007-08-28 2009-12-15 Quest Technologies Particulate monitor
ES2830024T3 (es) 2007-10-19 2021-06-02 Novartis Ag Composiciones y métodos para el tratamiento del edema macular
US8080562B2 (en) 2008-04-15 2011-12-20 Sarcode Bioscience Inc. Crystalline pharmaceutical and methods of preparation and use thereof
WO2011050175A1 (en) 2009-10-21 2011-04-28 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
EP2496079A4 (en) 2009-11-06 2014-05-14 Pierre Fabre Médicament Sas NOVEL (1S, 2R) -2- (AMINOMETHYL) -N, N-DIETHYL-1-PHENYLCYCLOPROPANECARBOXAMIDE CRYSTALLINE FORMS
CN110922393A (zh) 2012-07-25 2020-03-27 诺华股份有限公司 Lfa-1抑制剂及其多晶型物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6153757A (en) 1995-12-08 2000-11-28 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors and intermediates useful for their preparation
BR9807678A (pt) 1997-02-11 2000-02-15 Pfizer Derivados de ácidos arilsulfonil-hidroxâmicos
US6225311B1 (en) * 1999-01-27 2001-05-01 American Cyanamid Company Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
US6387901B1 (en) 1999-07-06 2002-05-14 Pfizer Inc Alkyne containing metalloproteinase inhibitors
CA2357110A1 (en) * 2001-04-11 2002-10-11 American Cyanamid Company Method for the treatment of polycystic kidney disease
JP2005507937A (ja) 2001-11-01 2005-03-24 ワイス・ホールディングズ・コーポレイション マトリックスメタロプロテイナーゼおよびｔａｃｅ阻害剤としてのアレンアリールスルホンアミドヒドロキサム酸
GT200500139A (es) 2004-06-08 2005-07-25 Metodo para la preparacion de acidos hidroxamicos

Also Published As

Publication number Publication date
US20050272929A1 (en) 2005-12-08
AR049349A1 (es) 2006-07-19
US7179911B2 (en) 2007-02-20
PA8636101A1 (es) 2006-03-24
WO2005123706A9 (en) 2006-04-27
AR049073A1 (es) 2006-06-21
WO2005123705A1 (en) 2005-12-29
GT200500139A (es) 2005-07-25
US20050272928A1 (en) 2005-12-08
US7435732B2 (en) 2008-10-14
TW200610523A (en) 2006-04-01
WO2005123706A1 (en) 2005-12-29
PA8636301A1 (es) 2006-03-24

Similar Documents

Publication Publication Date Title
TW200612959A (en) Method for preparing hydroxamic acids
GB0719180D0 (en) New process
HK1088597A1 (en) Method for the production of substituted 3-aryl-butyl amine compounds
HK1081199A1 (en) Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3- azabicyclo [3,1,0] hexane-2-carboxylates or salts thereof
MY156319A (en) Spiroheterocyclic n-oxypiperidines as pesticides
IL178771A0 (en) 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides
IL174469A0 (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
MX2009003257A (es) Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina.
PL1758852T3 (pl) Podstawione związki cyklopentenu
NZ593874A (en) Nalmefene hydrochloride dihydrate
GEP20125512B (en) Process for synthesis of agomelatin
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
TW200728310A (en) Process for the preparation of ferri-succinylcasein
TW200619205A (en) A method for preparing irbesartan and intermediates thereof
WO2009134531A3 (en) Total synthesis of salinosporamide a and analogs thereof
EA200870038A1 (ru) Способ получения аминов
MXPA05013751A (es) Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales.
TW200619213A (en) A process for the preparation of organic compounds
TW200738650A (en) Process for synthesis of aryloxy diaminopyrimidines
MX2009006943A (es) Procedimiento para la mejor utilizacion del potencial de produccion de plantas transgenicas.
TW200740729A (en) Methods for preparing glutamic acid derivatives
NO20071817L (no) Fremgangsmate for a fremstille enantiomeriske imidazolforbindelser
ATE466003T1 (de) Herstellung von 2-aminothiazol-5- carbonsäurederivaten
MX2010000693A (es) Composicion farmaceutica que comprende un compuesto de 11-desoxi-prostaglandina y metodo para establilizar el compuesto.
RS20050563A (en) Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors